Redfield D.C., Overturf G.D., Ewing, N.P., & Powars D.R. Bacteremia: Arthritis and Skin Lesions Due to Kingella Kingae. Arch Dis. Childh., 55, 441, 1980.
Ewing, N.P., Powars D.R., Hilburn J., & Schroeder W.A.: Newborn Diagnosis of Abnormal Hemoglobins from a Large Municipal Hospital in Los Angeles. American Journal of Public Health, 71, 629-631, 1981.
Ewing, N.P., et al.: Issues Surrounding Genetic Screening Programs. American Journal of Public Health, 71, 1411, 1981.
Marshall G.J., Powars D., Ewing, N.P. & Kirchen M.: Neutrophilic Phagocytosis in Autoimmune Thrombocytopenia Purpura. American Journal of Pediatric Hematology/Oncology, 4, 375-383, 1982.
Ewing N.P., & Kasper C.K.: In Vitro Detection of Mild Inhibitors to Factor VIII in Hemophilia. American Journal of Clinical Pathology, 77, 749-752, 1982.
Kasper C.K. & Ewing, N.P.: Measurement of Inhibitor of Factor VIII:C (and IX:C) in A.L. Blood (ed.), Methods in Haematology: The Haemophilias. Churchill Livingstone, 1982.
Kasper C.K., & Ewing, N.P.: Experience with the Bethesda Assay and Other Methods of Inhibitor Detection. Activated Prothrombin Complex Concentrates, in G. Mariani, M.A. Russo & F. Mandelli (eds), Managing Hemophilia with Factor VIII Inhibitor, 1982.
Meyer P.R., Modlin R.L., Powars D., Ewing N.P., Parker J.W., & Taylor C.R.: Altered Distribution of T-Lymphocyte Sub-population in Lymph Nodes from Patients with Acquired Immunodeficiency-like Syndrome and Hemophilia. The Journal of Pediatrics, 103, 407-410, 1983.
Kasper C.K., Boylen A.L., Ewing N.P., Luck J.V., Dietrich S.L.: Hematologic Management of Hemophilia A for Surgery. JAMA 253, 1279-1283, 1985.
Ewing, N.P.: Malignant Bone Tumors in R.L. Simmons, Reach for Fitness. Warner Books, Inc., 1986.
Kasper C.K., & Ewing N.P.: Acquired Inhibitors of Plasma Coagulation Factors. Journal of Medical Technology, 3, 431-439, 1986.
Ewing, N.P., Sanders N.L., Dietrich S.L., and Kasper C.K.: Induction of Immune Tolerance to Factor VIII in Hemophiliacs with Inhibitors. JAMA 259, 65-68, 1988.
Cattaneo M., Gringeri A., Mannucci P., Ewing, N.P., Sanders N.L., Dietrich S.L., Kasper C.K.: Induction of Immune Tolerance in Hemophiliacs with Inhibitors. JAMA Vol 258, No. 22, 1988.
Schwartz R.S., Ewing N.P., Gorenc T.J., and Spero J.A.: Comparative Efficacy of Non-heated and Heat-Treated Factor IX Complex Concentrate in Treatment of Hemophiliacs with Inhibitors. American Journal of Hematology 30:22-26, 1989.
Ewing, N.P., Induction of Immune Tolerance with Factor VIII Concentrate. Progress in Clinical Biology and Medicine, 1989.
Mariani G., Scheibel E., Nogao T., Kasper C.K., Ewing N.P., Mauser-Bunschoten E., Ghirardini A., Bellocco R., and Brackman H.H., for the participants in the International Registry of Immune Tolerance Protocols: Immune tolerance as treatment of alloantibodies to factor VIII in hemophilia. Seminars in Hematology, Vol 31, No. 2, Suppl; 4 (April), 62-64, 1994.
Ewing, N.P.: Induction of Immune Tolerance, the Future of the Registry, Vox Sanguinis;70 (Suppl 1):47-51, 1996.
Powars D., Conti P., Wong W., Groncy P., Hyman C., Smith E., Ewing N.P., Keenan R., Zee C., Harold Y., Hiti A., Teng E.: Cerebral Vasculopathy in Sickle Cell Anemia: diagnostic contribution of positron emission tomography. Blood, Vol 93, No. 1, 71-79, 1999.
Kulkarni R., Aledort L., Berntorp E., Brackman H.H., Brown D., Cohen A.R., Ewing, N.P., Gringeri A., Gruppo R., Hoots K., Leissenger C., Peerlinck K., Poon M.-C., and Wong, W.-Y.: Therapeutic Choices for Patients with Hemophilia and High-Titer Inhibitors. American Journal of Hematology, 67:240-246, 2001.
Becton, D.L., Ewing, N.P., Valentino, L.A.: Therapeutic strategies to prevent Joint Damage in Patients with Inhibitors to Factor VIII. Editor: Leissinger, C.A. CME Monograph, 2005.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.
